Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces Giant Food Now Carrying Alkaline88, A88 Infused Products

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), a producer of premium bottled alkaline water, flavor-infused waters and CBD-infused products sold under the brand names Alkaline88(R), A88 Infused(TM) and A88CBD(TM), has announced its products will now be available in Giant Food, the largest food retailer in the Mid-Atlantic region. A subsidiary of Ahold Delhaize, Giant Food is comprised of 164 stores in Maryland, Virginia, Delaware and Washington, DC. Alkaline88 has built a reputation for offering superior hydration with a perfect 8.8pH balance. Originally developed to deliver a Deliciously Smooth(TM) taste that encourages people to drink more and fully hydrate, the Alkaline88 line was the beginning of WTER’s growth and success. The flagship brand of premium alkaline water is now available in 75,000 stores across the United States. “This is our biggest win to date in the Mid-Atlantic region,” said The Alkaline Water Company president and CEO Ricky Wright in the press release. “Giant Food is the largest retailer in that market of 60 million people with over $5 billion in sales. While many retailers will test one or two product offerings, we are pleased to announce that Giant Food is carrying six products from our Alkaline88 and A88 Infused lines in their 164 locations. The products include our one-gallon and 1.5-liter bottles, and naturally flavored Watermelon, Raspberry, Blood Orange, and Lemon single serves. This year, we expect these and our other single serves to significantly increase their overall contribution to our top line. We couldn’t have hoped for a better start to our fiscal 2022 expansion into the Mid-Atlantic and Northeast regions than being on the shelves in Giant Food. This is just the beginning of a larger push into the remaining untapped markets in the U.S.”

To view the full press release, visit https://cnw.fm/SjgCx

About The Alkaline Water Company

Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88(R) delivers perfect 8.8 pH balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked Clean Beverage label. Quickly being recognized as a growing lifestyle brand, Alkaline88(R) launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused(TM) flavored water is available in six unique all-natural flavors, with new flavors coming soon. Additionally, in 2020, the company launched A88 Infused Beverage Division Inc., which includes the company’s CBD water and flavor-infused water. For the company’s topical and ingestible offerings, A88 Infused Products includes both the company’s lab-tested, full-spectrum hemp-extract salves, balms, lotions, essential oils, bath salts, powder packs, oil tinctures, capsules and gummies. To learn more about the company, please visit www.A88CBD.com and www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://cnw.fm/WTER

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Marijuana Cuts Migraine Pain, Headache by Almost Half, New Study Finds

A lot of people who have used cannabis regularly report that it has pain-relieving effects. But since cannabis has been illegal and intensely policed for such a long time, researchers have barely been able to conduct any research into its alleged health benefits. However, with more than 30 states legalizing cannabis in some form, the controversial drug is finally coming out from under the yoke of prohibition, and this has allowed scientists to take at a closer look at its medical capabilities.

A recent study, which was published in the “Journal of Pain” has confirmed what many cannabis users have known for years: marijuana has the ability to effectively manage pain. Specifically, researchers from Washington State University found that cannabis can reduce migraine and headache pain by half. On top of that, it does so without causing “overuse headaches,” which is when pharmaceutical painkillers actually worsen the patients’ headaches over time with continued use.

Led by Carrie Cuttler, an assistant professor of psychology at Washington State University, the researchers studied “big data” provided by the Strainprint app, which captured data from patients about their symptoms before and after using medical cannabis. More than 1,300 patients suffering from headaches submitted their information in real time, using the application over 12,200 times. Additionally, 650 patients with migraines also tracked changes in the severity of their conditions, using the app more than 7,400 times.

The inhaled medical marijuana, which the patients sourced from producers and distributors in Canada, reduced the migraine severity by 49.6% and headache severity by 47.3%. According to Cuttler, she and her team approached the study in an “ecological way,” looking at actual medical marijuana patients who used whole-plant cannabis to address headaches and migraines in their own homes and environments. Since the archival data provided by the Strainprint app was so immense, it allowed them the researchers to make accurate generalizations to estimate how most patients who used medical cannabis to address headaches and migraines fared.

Although they found no evidence that cannabis led to overuse headaches, which are often caused by regular use of pharmaceutical painkillers, the researchers did notice that the patients used larger doses of cannabis over time. This may be an indication that they developed a tolerance to cannabis the longer they used it and required larger doses to achieve the same effect. They also found that 90% of men reported more sessions to reduce their pain compared to 89.1% of women.

Cannabis concentrates such as cannabis oil were more effective in terms of reducing the severity of headaches and migraines compared to cannabis flower. Surprisingly, the data also indicated that the levels of THC (delta-9 tetrahydrocannabinol) and CBD (cannabidiol), whether higher or lower, did not have a significant impact on pain reduction. As such, it seems that the other less-studied cannabinoids (cannabis produces more than 100 cannabinoids), as well as terpenes and other compounds, may work together and cause a positive effect on marijuana’s pain-relieving capabilities.

However, Cuttler acknowledges the WSU study had several limitations, including the fact that it used data from a self-selected group of patients and had no placebo control group, and that more research is needed. Still, the study is a step in the right direction.

As more studies uncover the therapeutic uses of different cannabis compounds, the extracts and concentrates manufactured by companies such as Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) are likely to find their way into many novel products as people look for additional ways to get their dose of medical cannabis.

NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) are available in the company’s newsroom at https://cnw.fm/PULL

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Researchers Develop Peptide That Allows Medical Cannabis to Alleviate Pain Without Inducing Side Effects

Researchers have created a peptide that can allow THC to combat pain without inducing the side effects it causes, as observed in mice. This could potentially bring relief to many individuals living with chronic pain and who have no access to medical marijuana.

Data from the CDC shows that nearly 20% of grownups in the United States suffered from chronic pain in the year 2019.

Opioids are the primary medication prescribed for severe pain management and are effective. However, they are easily addictive which has prompted many physicians to stop prescribing them, leaving patients who suffer from chronic pain with fewer options.

The study findings were published in the American Chemical Society’s Journal of Medicinal Chemistry.

Prior studies have shown that medical cannabis can be useful in alleviating pain from cancer, neuropathy and migraines, as well as other conditions. However, the side effects observed present issues for the herb’s extensive use as a therapeutic.

Before the study, scientists had discovered a pair of peptides that interrupt interactions between a receptor that binds a neurotransmitter which regulates memory, learning among other cognitive functions as well as serotonin and another receptor that THC targets.

During their study, the researchers injected the peptides into the brains of mice, noting that some of the mice used had lesser memory problems that had been brought about by the THC.

The team, which was made up of researchers like David Andreu and Rafael Maldonado, worked to enhance these peptides by making them orally active, more stable, smaller and able to cross the brain-blood barrier.

To do this, the scientists developed optimized peptides that could still bind to receptors among other things but were smaller in length, in comparison with the original ones. They also used the data obtained from molecular dynamic simulations to improve the peptide sequences for stability, enhanced cell entry and capacity to cross the blood-brain barrier.

After this, the scientists orally administered the peptide to the mice and also injected them with THC, before testing the mice’s memory and pain threshold.

The researchers discovered that the mice that received the optimized peptide and the THC formulation had their pain alleviated in addition to demonstrating improved memory, in comparison with mice that had been treated with the THC formulation alone.

They also found that multiple treatments using the peptide didn’t elicit an immune response. The researchers’ discoveries suggest that the optimized peptide was an ideal candidate for decreasing the cognitive side effects from marijuana-based pain management.

Such studies confirm that the people who have been buying medical marijuana products manufactured by firms like Grapefruit USA Inc. (OTCQB: GPFT) were not disguised recreational users but instead had real medical concerns they needed to address.

NOTE TO INVESTORS: The latest news and updates relating to Grapefruit USA Inc. (OTCQB: GPFT) are available in the company’s newsroom at http://cnw.fm/GPFT

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

HempNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Positioned for Success in 2021 and Beyond

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leader in the health and wellness cannabidiol (“CBD”) industry, is keen on expanding its international distribution channels, demonstrating its compliance with regulatory standards for hemp-derived products worldwide, and seeking to expand access points for CBD. The company’s HempFusion USA, through Probulin Probiotics LLC, sells its products in about 4,000 retail locations in all 50 U.S. States. “Probulin’s network for probiotics sales has proved useful for helping the company gain an entry point in marketplaces hesitant to consider CBD,” reads a recent article. In March, the company announced Probulin’s entry into the Asian market through Tmall Global and, in April, announced its products had received Tmall’s conditional approval. HempFusion also sells its Probulin products in Mexico, South Korea, the United Arab Emirates, and Ireland with expectations of entering India and the United Kingdom. According to an April operational update by the company, “COVID and continued lack of clarity from the FDA related to official regulatory guidance for CBD used in dietary supplements, foods and beverages has made 2020 a challenging year. However, these challenges have led to strategic changes, establishing the foundation for HempFusion to succeed in 2021 and beyond.”

To view the full article, visit https://cnw.fm/7MLWW

About HempFusion Wellness Inc.

HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to approximately 4,000 retailers across all 50 US states and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs, including tinctures, proprietary FDA Drug-listed over-the-counter (“OTC”) topicals, doctor/practitioner lines, and more. With a strong focus on R&D, HempFusion has an additional 30 products under development. HempFusion is a board member of the U.S. Hemp Roundtable, and HempFusion’s wholly-owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in-store or by visiting HempFusion online at www.Hempfusion.com or www.Probulin.com.

NOTE TO INVESTORS: The latest news and updates relating to CBDHF are available in the company’s newsroom at https://cnw.fm/CBDHF

About HempWire

HempWire (HW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWire (HW) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.HempWire.com/Disclaimer

Do you have questions or are you interested in working with HW? Ask our Editor

HempWire (HW)
Denver, Colorado
www.HempWire.com
303.498.7722 Office
Editor@HempWire.net

HempWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Leading the Independent Pack, Poised in Market Projected to Hit $1B

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER) achieved $41.1 million in revenue for fiscal year 2020, representing a 28% year-over-year increase as reflected in its most recent financial report. Now the largest independent alkaline water company in the nation, the company’s accomplishment to lead the pack is impressive and positions it well as the market is projected to reach $1 billion in 2022 (https://cnw.fm/oXjm6). “WTER has shown consistent growth since the release of its flagship product: Alkaline88(R). Alkaline88 ionized water contains only two ingredients — water and Pink Himalayan rock salt — and has built a reputation for superior hydration with a perfect 8.8 pH balance. The brand was formulated to offer a smooth taste that encourages consumers to drink more and fully hydrate, key factors in maintaining health and wellness,” reads a recent article. “Alkaline88 is now available in more than 75,000 retail stores nationwide, and in addition to being number one in the indie alkaline water space, the brand has captured a prestigious spot as one of the top-10 largest enhanced water brands in the country as well. As per Nielsen data, the brand is the only top-10, nonflavored, value-added water brand that has consistently grown double digits in both units and dollar volume every four-week period since the end of 2019. In addition, research indicates that Alkaline88 has the greatest brand loyalty among alkaline water drinkers.”

To view the full article, visit https://cnw.fm/SJO2X

About The Alkaline Water Company

Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. Quickly being recognized as a growing lifestyle brand, Alkaline88 launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused flavored water is available in six unique, all-natural flavors with new flavors coming soon. Additionally, in 2020, the company launched A88 Infused Beverage Division Inc., which includes the company’s CBD water and flavor-infused water. For the company’s topical and ingestible offerings, A88 Infused Products Inc. includes the company’s lab-tested, hemp-extract salves, balms, lotions, essential oils, bath salts, powder packs, oil tinctures, capsules, and gummies. To learn more about the company, visit www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://cnw.fm/WTER

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Announces Purchase Order from British Columbia Liquor Distribution Branch

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, has received an initial purchase order (“PO”) for its proprietary cannabis vape cartridges through its wholly owned subsidiary Pure Extracts Manufacturing Corp. The PO, which is an initial order for the company’s 1-gram, full-spectrum oil (“FSO”), cannabis vape cartridges, was received from the Liquor Distribution Branch (“LDB”). According to the announcement, demand for Pure Extracts’ Pure Pulls branded vape carts is growing as consumer preferences mature and trend toward larger cartridges. Pure Extract’s 510 vape cartridges are produced by a global manufacturer and meet the highest North American test standards. LDB chose PULL’s cartridges for the quality of their component parts as well as their fit and finish and their performance characteristics; the cartridges will be filled with a selection of some of Pure Extract’s more than 30 proprietary cannabis FSO formulations. “We are excited to have received our first PO for 1 gram vape cartridges from the LDB, responsible for the wholesale distribution and retail sale of nonmedical cannabis in BC,” said Pure Extracts Technologies Corp. CEO Ben Nikolaevsky in the press release. “The combination of a larger format offering with our exceptional cannabis extracts will definitely build on the loyal following Pure Pulls already has in place. We are proud to be a leading innovator in the cannabis vape sector and look forward to providing additional SKUs to the LDB.”

To view the full press release, visit https://cnw.fm/JEXm5

About Pure Extracts Technologies Corp.

Pure Extracts features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia. The bespoke facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available. Health Canada, under the Cannabis Act, granted Pure Extracts its Standard Processing License on Sept. 25, 2020. In addition, the company’s stock began trading on the Canadian Securities Exchange (“CSE”) on Nov. 5, 2020. For more information about the company, please visit www.PureExtractsCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to PULL are available in the company’s newsroom at https://cnw.fm/PULL

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Launches High Times Branded Vapes Throughout Michigan

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, today announced the successful launch of High Times branded vapes into the Michigan market. Building on RWB’s partnerships and the successful launch of High Times branded packaged flower and pre-rolls earlier in the year, the company is pleased to introduce the High Times branded vapes, offered as premium live resin and distillate cartridges. The High Times branded vapes and previously launched products are available at 22 of Michigan’s finest dispensaries, while the High Times branded product portfolio will be made available to a significant number of the 250+ dispensaries in the state in the second half of 2021. “As I’ve stated before, we look forward to bringing exceptional quality, price and experience through our house of brands and product lines to loyal consumers in Michigan,” said Brad Rogers, RWB’s chairman and CEO. “We have been able to utilize partnerships in Michigan to establish branded product sales and are currently in the final steps of establishing our own operations in Michigan to allow us to utilize all that we have learned and leverage the investments we have made to accelerate that growth.”

To view the full press release, visit https://cnw.fm/Gl9zS

About Red White & Bloom Brands Inc.

The company is positioning itself to be one of the top three multistate cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on the major U.S. markets, including Michigan, Illinois, Florida, California, Oklahoma, Arizona, and Massachusetts with respect to cannabis, and the U.S. and internationally for hemp-based CBD products. For more information about the company, visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://cnw.fm/RWBYF

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Researchers Find Marijuana May Be Used to Alleviate Pain Caused by Sickle Cell

A clinical trial that was conducted by researchers from the University of California-Irvine in collaboration with UC San Francisco has found that marijuana has the potential to be used as a treatment for chronic pain in patients suffering from sickle cell disease. The trials discoveries were reported in JAMA Network Open.

Prof. Kalpna Gupta, who is a member of the Irvine institution’s Center for the Study of Cannabis as well as being an Irvine researcher, states that the trial led them to the discovery that vaporized marijuana is generally safe, suggesting that patients suffering from sickle cell anemia may alleviate their pain using marijuana, which may also be used to address the opioid crisis.

Gupta, who has specialized in medicine, adds that larger studies that have more participants may present researchers with a better view of how marijuana can help individuals suffering from chronic pain.

Opioids are the principal drugs prescribed to manage acute and chronic pain caused by sickle cell disease. However, the increase in deaths linked to opioids has prompted clinicians to prescribe them less, which leaves patients with chronic pain with fewer options.

The placebo-controlled, double-blind randomized trial conducted by the pair of institutions was the first to make use of gold-standard techniques to evaluate the potential of marijuana in pain relief for people suffering from sickle cell disease. The marijuana utilized in the trial contained equal parts of CBD and THC and was acquired from the National Institute on Drug Abuse, which is under the NIH.

Gupta stated that facing so much pain caused many individuals to turn to marijuana, adding that this was the main reason why people sought the herb from dispensaries. She explained that while researchers weren’t sure whether all forms of marijuana products would have the same effect on chronic pain, they were certain that vaporized marijuana was safer in comparison with other forms, as small amounts reach the body’s circulation.

For the trial, 23 patients who each suffer from pain related to sickle-cell disease were recruited. During the two 5-day inpatient sessions, which were separated by a 4-week period, each patient inhaled a vaporized placebo or vaporized marijuana.

The researchers then evaluated the pain level of each participant throughout the treatment period, which led to the discovery that marijuana’s efficaciousness grew over time. The participants also revealed that their pain didn’t affect their moods or activities such as sleeping and walking.

In addition to this, the researchers note that the level of pain was lower in patients who had inhaled vaporized marijuana in comparison with those who had received the placebo.

With companies such as RYAH Group Inc. (CSE: RYAH) making smart inhalers that allow patients to be sure about the amount of medical marijuana they are inhaling for pain, it may just be a matter of time before cannabis medicine is as widely accepted as pharmaceuticals.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. (CSE: RYAH) are available in the company’s newsroom at https://cnw.fm/RYAH

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — California Earmarks $100M to Support Licensed Cannabis Firms During Pandemic

For many states with legal cannabis markets, one of the objectives of legalizing the controversial drug was to cripple the illicit cannabis market by taking away its clientele. While that sounds like a great idea in theory, most of these states have been unable to do any real damage to the illegal market so far. Not only do black market sellers tend to price their cannabis cheaply, but they don’t have to jump through a wide variety of hoops to start selling, and this ensures the black market has an unending supply of affordable cannabis.

California, for instance, legalized marijuana back in 2016, but a mere four years later, the state’s illicit cannabis market has more than three times the number of registered cannabis sellers. Consequently, the state has earmarked $100 million towards supporting its struggling cannabis industry amid the coronavirus and subsequent financial crisis. State Governor Gavin Newsom proposed a measure that would see these funds used to help businesses in the cannabis space turn their provisional licenses into permanent licenses, and it was recently approved by the legislature.

According to Newsom’s office, around 82% of licensed businesses hold provisional licenses, with most cannabis businesses being unable to convert those licenses to permanent ones due to the high costs involved. The state requires permanent license holders to run their businesses in a way that has minimal to zero negative environmental impact, and this usually leads to higher annual operational costs. As many of the registered operators are equity applicants, small businesses and legacy operators, says Newsom’s senior cannabis advisor Nicole Elliot, these costs are often more than they can handle, preventing them from obtaining permanent licenses.

This one-time $100 million grant will be used to help cities in the state employ professionals and staff to assist with the process of turning provisional licenses into permanent ones as well as to aid in business operations. Los Angeles alone will receive $22 million, with the rest of the funds going to cities such as Oakland, San Francisco, Adelanto, Commerce and Desert Hot Springs. Matt Hawkins, managing partner at Entourage Effect Capital and the board chair at Harborside, says the grant will help ease the financial burden on legal companies and allow regulators to process the backlog of licenses much faster.

Newsom has also thrown his weight behind a measure that would extend the Jan. 6, 2022, deadline to apply for provisional licenses by six months. However, it wasn’t included in the most recent state budget bill, and lawmakers are still discussing it.

It is heartwarming to sector players such as XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) to learn that some jurisdictions are taking steps to support the cannabis industry during the pandemic. This is a far cry from the stance of the federal government, which doesn’t recognize state-level cannabis firms as legitimate business concerns.

NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://cnw.fm/XPHYF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CBDNewsBreaks – Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) Names New Chief Integration Officer, Fifth & Root GM

Chalice Brands (CSE: CHAL) (OTCQB: CHALF), a premier consumer-driven cannabis company formerly known as Golden Leaf Holdings Ltd., has announced the appointment of a new member of management. Ginger Mollo will served as chief integration office for Chalice Brands and general manager for Fifth & Root; a nationally recognized CBD skincare brand. In her new roles, Mollo will oversee positioning and growing the Fifth & Root Brand within the health and wellness beauty market in addition to integrating the products within the Chalice brands. A veteran in retail and company development, Mollo has worked at companies such as Limited Brands and Apple, where she helped create the Apple stores. CHALF has also retained MP- Integrated Marketing Communications (“MP-IMC”); the company will assist with Fifth & Root public relations, marketing communications and brand building efforts. “We are thrilled to add Ginger, the woman who had her fingertips on Apple stores, bring us her high-achieving, goal-focused, and innovative mover-and-shaker expertise, with over 20 years of retail experience to Fifth & Root,” said Chalice Brands CEO and president Jeff Yapp in the press release. “We look forward to benefitting from Ginger’s experience in the progressive retail space to elevate the structure and style of Fifth & Root to the next level. She brings many years of interpersonal communication, collaborative problem solving and critical thinking to the leadership team. . . . We are [also] pleased to announce that we have engaged MP-IMC to heighten the profile of Fifth & Root in our Chalice Brands product portfolio. We look forward to working with Melissa and her team to enhance the essence of Fifth & Root.”

To view the full press release, visit https://cnw.fm/mu1Am

About Chalice Brands Ltd.

Chalice Brands is a premier consumer-driven cannabis company specializing in production, processing, wholesale, distribution and retail with 12 dispensaries in Portland, Oregon. The company is committed to developing a dynamic portfolio built around the recognized brands of Chalice Farms, with a focus on health and wellness. Chalice operates nationally through Fifth & Root and has operations in Oregon and California. For more information about the company, visit https://investors.ChaliceBrandsLtd.com.

NOTE TO INVESTORS: The latest news and updates relating to CHALF are available in the company’s newsroom at https://cnw.fm/CHALF

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.